COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 2482: Articles 24811-24820  | Next

Reducing COVID-19 hospitalization risk through behavior change
ADAMS, M. L., Katz, D. L., Grandpre, J., Shenson, D.
10.1101/2020.07.21.20159350 — Posted: 2020-07-24
Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: a population-based cohort study from Italy
Orlando, V., Rea, F., savare, L., Guarino, I., Mucherino, S., Perrella, A., Trama, U., Coscioni, E., Menditto, E., Corrao, G.
10.1101/2020.07.23.217331 — Posted: 2020-07-23
The new silicone N99 half-piece respirator, VJR-NMU N99: A novel and effective tool to prevent COVID-19
Trakarnvanich, T., Manomaipiboon, A., Pupipatpab, S., Chomdee, P. C., Boonyapatkul, P.
10.1101/2020.07.23.217372 — Posted: 2020-07-23
Oral delivery of SARS-CoV-2 DNA vaccines using attenuated Salmonella typhimurium as a carrier in rat
Yang, D., Zhu, D., Meng, Y., Qimuge, A., Bilige, B., Baiyin, T., Temuqile, T., Chen, S., Borjigen, S., Baigude, H.
10.1101/2020.07.23.217174 — Posted: 2020-07-23
SARS-CoV2 genome analysis of Indian isolates and molecular modelling of D614G mutated spike protein with TMPRSS2 depicted its enhanced interaction and virus infectivity
Raghav, S., Ghosh, A., Turuk, J., Kumar, S., Jha, A., Madhulika, S., Priyadarshini, M., Biswas, V. K., Shyamli, P. S., Singh, B., Singh, N., Singh, D., Kiran, A., Smita, S., Sabat, J., Bhattacharya, D., Dash, R., Senapati, S., Beuria, T. K., Swain, R., Chattopadhyay, S., Syed, G. H., Dixit, A., Prasad, P., Pati, S., Parida, A.
10.1101/2020.07.23.217430 — Posted: 2020-07-23
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
An, X., Martinez, M. P., Rezvan, A., Fathi, M., Singh, S., Biswas, S., Pourpak, M., Yee, C., Liu, X., Varadarajan, N.
10.1101/2020.07.23.212357 — Posted: 2020-07-23
SARS-CoV-2-induced humoral immunity through B cell epitope analysis and neutralizing activity in COVID-19 infected individuals in Japan
Yoshida, S., Ono, C., Hayashi, H., Shiraishi, S., Kazunori, T., Arase, H., Matsuura, Y., Nakagami, H.
10.1101/2020.07.22.212761 — Posted: 2020-07-23
Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy
Shabalin, I. G., Czub, M. P., Majorek, K. A., Brzezinski, D., Grabowski, M., Cooper, D. R., Panasiuk, M., Chruszcz, M., Minor, W.
10.1101/2020.07.21.212704 — Posted: 2020-07-23 Discussion: Onsite
Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
Oark, J.-G., Oladduni, F. S., Chiem, K., Ye, C., Pipenbrink, M., Moran, T., Walter, M., Kobie, J., Martinez-Sobrido, L.
10.1101/2020.07.22.216648 — Posted: 2020-07-23
SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 is expressed in human pancreatic islet β-cells and is upregulated by inflammatory stress
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C., Colli, M. L., Marchetti, P., Mathieu, C., Eizirik, D. L., Sebastiani, G., Dotta, F.
10.1101/2020.07.23.208041 — Posted: 2020-07-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).